Page last updated: 2024-09-03

clofarabine and ribociclib

clofarabine has been researched along with ribociclib in 1 studies

Compound Research Comparison

Studies
(clofarabine)
Trials
(clofarabine)
Recent Studies (post-2010)
(clofarabine)
Studies
(ribociclib)
Trials
(ribociclib)
Recent Studies (post-2010) (ribociclib)
42410128033056322

Protein Interaction Comparison

ProteinTaxonomyclofarabine (IC50)ribociclib (IC50)
Cyclin-T1Homo sapiens (human)1.1228
Cyclin-dependent kinase 4Homo sapiens (human)0.0156
G1/S-specific cyclin-D1Homo sapiens (human)0.0235
G1/S-specific cyclin-D3Homo sapiens (human)0.0352
Cyclin-dependent kinase 9Homo sapiens (human)1.1228
Cyclin-dependent kinase 6Homo sapiens (human)0.0393

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, XB; Wang, S; Wang, SQ; Yu, B; Yuan, XH; Zhao, W1

Reviews

1 review(s) available for clofarabine and ribociclib

ArticleYear
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application.
    European journal of medicinal chemistry, 2021, Mar-15, Volume: 214

    Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Humans; Molecular Structure; Neoplasms; Pyrimidines; United States; United States Food and Drug Administration

2021